Disc Medicine to Participate in Upcoming Investor Conferences

IRON 11.13.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-19
Name of Upcoming Event:Stifel 2024 Healthcare Conference
Date of Upcoming Event:2024-11-21
Name of Upcoming Event:Jefferies London Healthcare Conference
Full Press ReleaseSEC FilingsOur IRON Tweets

About Gravity Analytica

Recent News

  • 01.23.2025 - Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
  • 01.21.2025 - Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
  • 01.21.2025 - Disc Medicine Type C Meeting for Bitopertin in EPP Conference Call

Recent Filings

    WATERTOWN, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will present at two upcoming investor conferences:

    • Stifel 2024 Healthcare Conference on Tuesday, November 19that 8:35 a.m. ET.
    • Jefferies London Healthcare Conference on Thursday, November 21stat 9:30 a.m. GMT.

    A live webcast of the presentations will be available through the investor relations section of the Company's website atir.discmedicine.comand an archived replay will be available after the event.

    About Disc Medicine

    Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visitwww.discmedicine.com.

    Media Contact

    Peg RusconiDeerfield Grouppeg.rusconi@deerfieldgroup.com

    Investor Relations Contact

    Christina TartagliaPrecision AQchristina.tartaglia@precisionaq.com

    Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com